{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T17:39:24Z","timestamp":1771522764157,"version":"3.50.1"},"reference-count":52,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100017596","name":"Natural Science Basic Research Program of Shaanxi Province","doi-asserted-by":"publisher","award":["2024JC-YBMS-691"],"award-info":[{"award-number":["2024JC-YBMS-691"]}],"id":[{"id":"10.13039\/501100017596","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100017596","name":"Natural Science Basic Research Program of Shaanxi Province","doi-asserted-by":"publisher","award":["2023-JC-YB-750"],"award-info":[{"award-number":["2023-JC-YB-750"]}],"id":[{"id":"10.13039\/501100017596","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81802456"],"award-info":[{"award-number":["81802456"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100031935","name":"Xi'an Jiaotong University","doi-asserted-by":"publisher","award":["YXJLRH2022063"],"award-info":[{"award-number":["YXJLRH2022063"]}],"id":[{"id":"10.13039\/100031935","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.intimp.2025.116014","type":"journal-article","created":{"date-parts":[[2025,12,13]],"date-time":"2025-12-13T00:44:40Z","timestamp":1765586680000},"page":"116014","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Macrophage DHX34 as a negative regulator of the CX3CL1\u2013CX3CR1 axis and CD8+ T-cell infiltration in hepatocellular carcinoma"],"prefix":"10.1016","volume":"169","author":[{"given":"Zeyu","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianing","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fei","family":"Du","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nanbin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chunli","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Limin","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Feng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chen","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jin","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gaixia","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guoying","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zongfang","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongwei","family":"Tian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"15","key":"10.1016\/j.intimp.2025.116014_bb0005","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.1200\/JCO.23.02745","article-title":"Systemic therapy for advanced hepatocellular carcinoma: ASCO guideline update","volume":"42","author":"Gordan","year":"2024","journal-title":"J. Clin. Oncol."},{"issue":"6","key":"10.1016\/j.intimp.2025.116014_bb0010","doi-asserted-by":"crossref","first-page":"1922","DOI":"10.1097\/HEP.0000000000000466","article-title":"AASLD practice guidance on prevention, diagnosis, and treatment of hepatocellular carcinoma","volume":"78","author":"Singal","year":"2023","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.intimp.2025.116014_bb0015","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1016\/j.jhep.2021.11.030","article-title":"Updated efficacy and safety data from IMbrave150: Atezolizumab plus bevacizumab vs. sorafenib for unresectable hepatocellular carcinoma","volume":"76","author":"Cheng","year":"2022","journal-title":"J. Hepatol."},{"issue":"10","key":"10.1016\/j.intimp.2025.116014_bb0020","doi-asserted-by":"crossref","first-page":"2188","DOI":"10.1016\/j.immuni.2023.09.011","article-title":"The cancer-immunity cycle: indication, genotype, and immunotype","volume":"56","author":"Mellman","year":"2023","journal-title":"Immunity"},{"key":"10.1016\/j.intimp.2025.116014_bb0025","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.655697","article-title":"Hepatocellular carcinoma immune landscape and the potential of immunotherapies","volume":"12","author":"Giraud","year":"2021","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.intimp.2025.116014_bb0030","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1038\/s41420-023-01356-7","article-title":"Targeting tumor-associated macrophages in hepatocellular carcinoma: biology, strategy, and immunotherapy","volume":"9","author":"Zheng","year":"2023","journal-title":"Cell Death Discov."},{"key":"10.1016\/j.intimp.2025.116014_bb0035","doi-asserted-by":"crossref","first-page":"1429812","DOI":"10.3389\/fimmu.2024.1429812","article-title":"Role of tumor-associated macrophages in hepatocellular carcinoma: impact, mechanism, and therapy","volume":"15","author":"Zhang","year":"2024","journal-title":"Front. Immunol."},{"issue":"2","key":"10.1016\/j.intimp.2025.116014_bb0040","doi-asserted-by":"crossref","first-page":"886","DOI":"10.3892\/or.2017.5738","article-title":"Intratumoral and peritumoral expression of CD68 and CD206 in hepatocellular carcinoma and their prognostic value","volume":"38","author":"Ren","year":"2017","journal-title":"Oncol. Rep."},{"issue":"3","key":"10.1016\/j.intimp.2025.116014_bb0045","doi-asserted-by":"crossref","first-page":"320","DOI":"10.3390\/ijms17030320","article-title":"CD86+\/CD206+, diametrically polarized tumor-associated macrophages, predict hepatocellular carcinoma patient prognosis","volume":"17","author":"Dong","year":"2016","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.intimp.2025.116014_bb0050","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1038\/s41392-023-01452-1","article-title":"Macrophages in immunoregulation and therapeutics","volume":"8","author":"Chen","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"issue":"23","key":"10.1016\/j.intimp.2025.116014_bb0055","doi-asserted-by":"crossref","DOI":"10.3390\/ijms252313167","article-title":"The role of macrophages in hepatocellular carcinoma and their therapeutic potential","volume":"25","author":"Bannister","year":"2024","journal-title":"Int. J. Mol. Sci."},{"issue":"4","key":"10.1016\/j.intimp.2025.116014_bb0060","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1016\/j.jhep.2023.01.011","article-title":"Identification of a tumour immune barrier in the HCC microenvironment that determines the efficacy of immunotherapy","volume":"78","author":"Liu","year":"2023","journal-title":"J. Hepatol."},{"issue":"1","key":"10.1016\/j.intimp.2025.116014_bb0065","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.jhep.2023.02.032","article-title":"TREM2(+) macrophages suppress CD8(+) T-cell infiltration after transarterial chemoembolisation in hepatocellular carcinoma","volume":"79","author":"Tan","year":"2023","journal-title":"J. Hepatol."},{"issue":"1","key":"10.1016\/j.intimp.2025.116014_bb0070","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1038\/s41568-023-00635-w","article-title":"How chemokines organize the tumour microenvironment","volume":"24","author":"Mempel","year":"2024","journal-title":"Nat. Rev. Cancer"},{"issue":"2","key":"10.1016\/j.intimp.2025.116014_bb0075","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1158\/1078-0432.CCR-19-1868","article-title":"Macrophage-derived CXCL9 and CXCL10 are required for antitumor immune responses following immune checkpoint blockade","volume":"26","author":"House","year":"2020","journal-title":"Clin. Cancer Res."},{"issue":"12","key":"10.1016\/j.intimp.2025.116014_bb0080","doi-asserted-by":"crossref","first-page":"5151","DOI":"10.1172\/JCI128644","article-title":"Hedgehog signaling promotes tumor-associated macrophage polarization to suppress intratumoral CD8+ T cell recruitment","volume":"129","author":"Petty","year":"2019","journal-title":"J. Clin. Invest."},{"issue":"1","key":"10.1016\/j.intimp.2025.116014_bb0085","doi-asserted-by":"crossref","first-page":"7709","DOI":"10.1038\/s41467-023-43462-1","article-title":"Low-dose radiotherapy combined with dual PD-L1 and VEGFA blockade elicits antitumor response in hepatocellular carcinoma mediated by activated intratumoral CD8(+) exhausted-like T cells","volume":"14","author":"Li","year":"2023","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.intimp.2025.116014_bb0090","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1186\/s13045-023-01487-5","article-title":"Synergistic efficacy of simultaneous anti-TGF-\u03b2\/VEGF bispecific antibody and PD-1 blockade in cancer therapy","volume":"16","author":"Niu","year":"2023","journal-title":"J. Hematol. Oncol."},{"issue":"23","key":"10.1016\/j.intimp.2025.116014_bb0095","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13236132","article-title":"Multifaceted roles of chemokines and chemokine receptors in tumor immunity","volume":"13","author":"Matsuo","year":"2021","journal-title":"Cancers (Basel)"},{"issue":"1","key":"10.1016\/j.intimp.2025.116014_bb0100","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1038\/s41392-024-01979-x","article-title":"Cold and hot tumors: from molecular mechanisms to targeted therapy","volume":"9","author":"Wu","year":"2024","journal-title":"Signal Transduct. Target. Ther."},{"issue":"1","key":"10.1016\/j.intimp.2025.116014_bb0105","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1038\/s41417-021-00303-x","article-title":"Key chemokines direct migration of immune cells in solid tumors","volume":"29","author":"Kohli","year":"2022","journal-title":"Cancer Gene Ther."},{"issue":"6617","key":"10.1016\/j.intimp.2025.116014_bb0110","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1038\/385640a0","article-title":"A new class of membrane-bound chemokine with a CX3C motif","volume":"385","author":"Bazan","year":"1997","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.intimp.2025.116014_bb0115","doi-asserted-by":"crossref","first-page":"571","DOI":"10.7150\/jca.47022","article-title":"Regulation and biological functions of the CX3CL1-CX3CR1 axis and its relevance in solid cancer: a mini-review","volume":"12","author":"Rivas-Fuentes","year":"2021","journal-title":"J. Cancer"},{"key":"10.1016\/j.intimp.2025.116014_bb0120","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/s40425-016-0125-1","article-title":"Enhanced recruitment of genetically modified CX3CR1-positive human T cells into Fractalkine\/CX3CL1 expressing tumors: importance of the chemokine gradient","volume":"4","author":"Siddiqui","year":"2016","journal-title":"J. Immunother. Cancer"},{"issue":"4","key":"10.1016\/j.intimp.2025.116014_bb0125","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/S0092-8674(00)80438-9","article-title":"Identification and molecular characterization of fractalkine receptor CX3CR1, which mediates both leukocyte migration and adhesion","volume":"91","author":"Imai","year":"1997","journal-title":"Cell"},{"issue":"8","key":"10.1016\/j.intimp.2025.116014_bb0130","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1084\/jem.188.8.1413","article-title":"Fractalkine and CX3CR1 mediate a novel mechanism of leukocyte capture, firm adhesion, and activation under physiologic flow","volume":"188","author":"Fong","year":"1998","journal-title":"J. Exp. Med."},{"issue":"16","key":"10.1016\/j.intimp.2025.116014_bb0135","doi-asserted-by":"crossref","first-page":"4779","DOI":"10.7150\/thno.32543","article-title":"The miR-561-5p\/CX(3)CL1 signaling Axis regulates pulmonary metastasis in hepatocellular carcinoma involving CX(3)CR1(+) natural killer cells infiltration","volume":"9","author":"Chen","year":"2019","journal-title":"Theranostics"},{"issue":"4","key":"10.1016\/j.intimp.2025.116014_bb0140","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2023.106443","article-title":"CX3CR1 deficiency-induced TIL tumor restriction as a novel addition for CAR-T design in solid malignancies","volume":"26","author":"Trinh","year":"2023","journal-title":"iScience"},{"issue":"4","key":"10.1016\/j.intimp.2025.116014_bb0145","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1002\/jso.23095","article-title":"High expression of CX3CL1 by tumor cells correlates with a good prognosis and increased tumor-infiltrating CD8+ T cells, natural killer cells, and dendritic cells in breast carcinoma","volume":"106","author":"Park","year":"2012","journal-title":"J. Surg. Oncol."},{"issue":"3","key":"10.1016\/j.intimp.2025.116014_bb0150","article-title":"Harnessing the chemokine system to home CAR-T cells into solid tumors","volume":"3","author":"Foeng","year":"2022","journal-title":"Cell Rep Med"},{"issue":"1","key":"10.1016\/j.intimp.2025.116014_bb0155","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1186\/s40001-025-02410-z","article-title":"HCC-derived CX3CL1 affects hepatocellular carcinoma prognosis and CX3CR1+MDSC infiltration","volume":"30","author":"Zhang","year":"2025","journal-title":"Eur. J. Med. Res."},{"issue":"16","key":"10.1016\/j.intimp.2025.116014_bb0160","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1038\/sj.gt.3302959","article-title":"Gene therapy with CX3CL1\/Fractalkine induces antitumor immunity to regress effectively mouse hepatocellular carcinoma","volume":"14","author":"Tang","year":"2007","journal-title":"Gene Ther."},{"issue":"8","key":"10.1016\/j.intimp.2025.116014_bb0165","article-title":"CX3CR1-CD8+ T cells are critical in antitumor efficacy but functionally suppressed in the tumor microenvironment. JCI","volume":"5","author":"Yamauchi","year":"2020","journal-title":"Insight"},{"issue":"1","key":"10.1016\/j.intimp.2025.116014_bb0170","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1186\/s12943-024-02097-6","article-title":"YTHDF2 in peritumoral hepatocytes mediates chemotherapy-induced antitumor immune responses through CX3CL1-mediated CD8(+) T cell recruitment","volume":"23","author":"Yang","year":"2024","journal-title":"Mol. Cancer"},{"issue":"8","key":"10.1016\/j.intimp.2025.116014_bb0175","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1038\/nrm3154","article-title":"From unwinding to clamping - the DEAD box RNA helicase family","volume":"12","author":"Linder","year":"2011","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.intimp.2025.116014_bb0180","doi-asserted-by":"crossref","first-page":"10585","DOI":"10.1038\/ncomms10585","article-title":"The RNA helicase DHX34 functions as a scaffold for SMG1-mediated UPF1 phosphorylation","volume":"7","author":"Melero","year":"2016","journal-title":"Nat. Commun."},{"issue":"6","key":"10.1016\/j.intimp.2025.116014_bb0185","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1016\/j.celrep.2014.08.020","article-title":"The RNA helicase DHX34 activates NMD by promoting a transition from the surveillance to the decay-inducing complex","volume":"8","author":"Hug","year":"2014","journal-title":"Cell Rep."},{"issue":"9","key":"10.1016\/j.intimp.2025.116014_bb0190","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1261\/rna.079277.122","article-title":"A dual role for the RNA helicase DHX34 in NMD and pre-mRNA splicing and its function in hematopoietic differentiation","volume":"28","author":"Hug","year":"2022","journal-title":"Rna"},{"issue":"20","key":"10.1016\/j.intimp.2025.116014_bb0195","doi-asserted-by":"crossref","first-page":"6594","DOI":"10.7150\/jca.102230","article-title":"DHX34 as a promising biomarker for prognosis, immunotherapy and chemotherapy in Pan-Cancer: a comprehensive analysis and experimental validation","volume":"15","author":"Liu","year":"2024","journal-title":"J. Cancer"},{"key":"10.1016\/j.intimp.2025.116014_bb0200","doi-asserted-by":"crossref","DOI":"10.1016\/j.neo.2025.101198","article-title":"DHX34 deficiency triggers tumor-intrinsic immunity via a dsRNA-mediated type I interferon pathway activation in HCC","volume":"67","author":"Zhang","year":"2025","journal-title":"Neoplasia"},{"issue":"D1","key":"10.1016\/j.intimp.2025.116014_bb0205","doi-asserted-by":"crossref","first-page":"D1425","DOI":"10.1093\/nar\/gkac959","article-title":"TISCH2: expanded datasets and new tools for single-cell transcriptome analyses of the tumor microenvironment","volume":"51","author":"Han","year":"2023","journal-title":"Nucleic Acids Res."},{"issue":"2","key":"10.1016\/j.intimp.2025.116014_bb0210","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.gpb.2022.08.004","article-title":"TIGER: a web portal of tumor immunotherapy gene expression resource","volume":"21","author":"Chen","year":"2023","journal-title":"Genomics Proteomics Bioinformatics"},{"issue":"1","key":"10.1016\/j.intimp.2025.116014_bb0215","doi-asserted-by":"crossref","DOI":"10.1016\/j.xpro.2020.100246","article-title":"Preparation and culture of bone marrow-derived macrophages from mice for functional analysis","volume":"2","author":"Toda","year":"2021","journal-title":"STAR Protoc"},{"issue":"1","key":"10.1016\/j.intimp.2025.116014_bb0220","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1369\/jhc.2010.957191","article-title":"Antigen retrieval immunohistochemistry: review and future prospects in research and diagnosis over two decades","volume":"59","author":"Shi","year":"2011","journal-title":"J. Histochem. Cytochem."},{"issue":"13","key":"10.1016\/j.intimp.2025.116014_bb0225","doi-asserted-by":"crossref","first-page":"3607","DOI":"10.1158\/0008-5472.CAN-20-3790","article-title":"Targeting DDX3X triggers antitumor immunity via a dsRNA-mediated tumor-intrinsic type I interferon response","volume":"81","author":"Choi","year":"2021","journal-title":"Cancer Res."},{"issue":"2","key":"10.1016\/j.intimp.2025.116014_bb0230","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2020-002045","article-title":"CXCL9-expressing tumor-associated macrophages: new players in the fight against cancer","volume":"9","author":"Marcovecchio","year":"2021","journal-title":"J. Immunother. Cancer"},{"issue":"3","key":"10.1016\/j.intimp.2025.116014_bb0235","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1136\/gutjnl-2011-300509","article-title":"Chemokine-driven lymphocyte infiltration: an early intratumoural event determining long-term survival in resectable hepatocellular carcinoma","volume":"61","author":"Chew","year":"2012","journal-title":"Gut"},{"issue":"1","key":"10.1016\/j.intimp.2025.116014_bb0240","doi-asserted-by":"crossref","first-page":"7825","DOI":"10.1038\/s41467-023-43381-1","article-title":"PD-1(\u2212) CD45RA(+) effector-memory CD8 T cells and CXCL10(+) macrophages are associated with response to atezolizumab plus bevacizumab in advanced hepatocellular carcinoma","volume":"14","author":"Cappuyns","year":"2023","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.intimp.2025.116014_bb0245","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1186\/s12885-022-10302-2","article-title":"CX3CL1 promotes cell sensitivity to ferroptosis and is associated with the tumor microenvironment in clear cell renal cell carcinoma","volume":"22","author":"Gong","year":"2022","journal-title":"BMC Cancer"},{"issue":"1","key":"10.1016\/j.intimp.2025.116014_bb0250","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1038\/s41467-021-21619-0","article-title":"T-cell CX3CR1 expression as a dynamic blood-based biomarker of response to immune checkpoint inhibitors","volume":"12","author":"Yamauchi","year":"2021","journal-title":"Nat. Commun."},{"issue":"11","key":"10.1016\/j.intimp.2025.116014_bb0255","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1158\/2326-6066.CIR-23-0627","article-title":"Blocking CX3CR1+ tumor-associated macrophages enhances the efficacy of anti-PD1 therapy in hepatocellular carcinoma","volume":"12","author":"Xiang","year":"2024","journal-title":"Cancer Immunol. Res."},{"issue":"3","key":"10.1016\/j.intimp.2025.116014_bb0260","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1097\/HEP.0000000000001021","article-title":"CX3CR1+ macrophages interact with HSCs to promote HCC through CD8+ T-cell suppression","volume":"82","author":"Jeong","year":"2025","journal-title":"Hepatology"}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S156757692502003X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S156757692502003X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T16:59:14Z","timestamp":1771520354000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S156757692502003X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":52,"alternative-id":["S156757692502003X"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2025.116014","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Macrophage DHX34 as a negative regulator of the CX3CL1\u2013CX3CR1 axis and CD8+ T-cell infiltration in hepatocellular carcinoma","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2025.116014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"116014"}}